Strong BuyLoad up.....the breakout is imminent! With another looming global explosion in hybrid stronger more lethal Covid cases are on the horizon.
The company has a weak cash position 38M, with minimal debt 2.6M. the company is cash flow negative bleeding money <24M>.
Historically the company has a dilution factor dating back to 2016 at 9M shares, currently standing at 32M O/S & floating
My price target is $30!
NFA